DK0870500T3 - Anti-helicobacter polyri-middel - Google Patents

Anti-helicobacter polyri-middel

Info

Publication number
DK0870500T3
DK0870500T3 DK96942589T DK96942589T DK0870500T3 DK 0870500 T3 DK0870500 T3 DK 0870500T3 DK 96942589 T DK96942589 T DK 96942589T DK 96942589 T DK96942589 T DK 96942589T DK 0870500 T3 DK0870500 T3 DK 0870500T3
Authority
DK
Denmark
Prior art keywords
helicobacter
polyri
agent
cyclodextrin
phenylüphenyl
Prior art date
Application number
DK96942589T
Other languages
English (en)
Inventor
Osamu Kamoda
Toshiharu Yanagi
Seiji Sato
Jun-Ichi Mizoguchi
Eiji-Teikoku Tamaki
Original Assignee
Nagase Chemtex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nagase Chemtex Corp filed Critical Nagase Chemtex Corp
Application granted granted Critical
Publication of DK0870500T3 publication Critical patent/DK0870500T3/da

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Emergency Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Cultivation Receptacles Or Flower-Pots, Or Pots For Seedlings (AREA)
DK96942589T 1995-12-22 1996-12-20 Anti-helicobacter polyri-middel DK0870500T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP35466095 1995-12-22
PCT/JP1996/003723 WO1997023207A1 (en) 1995-12-22 1996-12-20 Anti-helicobacter pylori agent

Publications (1)

Publication Number Publication Date
DK0870500T3 true DK0870500T3 (da) 2008-06-09

Family

ID=18439052

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96942589T DK0870500T3 (da) 1995-12-22 1996-12-20 Anti-helicobacter polyri-middel

Country Status (12)

Country Link
US (2) US20020123508A1 (da)
EP (1) EP0870500B1 (da)
JP (1) JP3468244B2 (da)
KR (1) KR100332280B1 (da)
AT (1) ATE386511T1 (da)
AU (2) AU1171697A (da)
DE (1) DE69637442T2 (da)
DK (1) DK0870500T3 (da)
ES (1) ES2301171T3 (da)
PT (1) PT870500E (da)
TW (2) TW457086B (da)
WO (1) WO1997023207A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4658306B2 (ja) * 2000-10-18 2011-03-23 ナガセ医薬品株式会社 錠剤用医薬組成物
US20080234182A1 (en) * 2007-03-22 2008-09-25 Innovative Biologics, Inc. Blockers of pore-forming virulence factors and their use as anti-infectives
JP2007538112A (ja) * 2004-01-29 2007-12-27 ピナクル ファーマシューティカルズ β−シクロデキストリン誘導体およびそれらの炭疽致死毒に対する使用
US20070092502A1 (en) * 2005-09-01 2007-04-26 Allergan, Inc. Method of Treating Glaucoma
PL2003130T3 (pl) 2006-03-10 2012-04-30 Link Genomics Inc Nowa pochodna pirydyny o aktywności przeciwko helicobacter pylori
US8715731B2 (en) * 2006-03-22 2014-05-06 Isp Investments Inc. Process of reducing the bitter taste of water soluble actives by co-grinding the active with β cyclodextrin
BRPI1014314A2 (pt) 2009-04-09 2019-09-24 Arigen Pharmaceuticals Inc derivado de tiopiridina, e, composição farmacêutica.
US12433853B2 (en) * 2019-08-26 2025-10-07 Kent State University Rationally designed lawsone derivatives as antimicrobials against multidrug-resistant Staphylococcus aureus
TW202535382A (zh) * 2023-11-29 2025-09-16 南韓商第一藥品股份有限公司 包含zastaprazan或其醫藥上可接受的鹽之用於幽門螺旋桿菌根除的組成物

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5692260A (en) 1979-12-26 1981-07-25 Nippon Chemiphar Co Ltd Cyclohexanecarboxylic ester and its preparation
JPS5645454A (en) 1979-09-20 1981-04-25 Nippon Chemiphar Co Ltd Cyclohexanecarboxylic acid derivative and its preparation
JPS5692261A (en) 1979-12-26 1981-07-25 Nippon Chemiphar Co Ltd Novel cyclohexanecarboxylic derivative and its preparation
JPS5716855A (en) 1980-07-04 1982-01-28 Teikoku Chem Ind Corp Ltd 4-guanidinomethylcyclohexanecarboxylic acid ester and its preparation
JPS5716856A (en) 1980-07-04 1982-01-28 Teikoku Chem Ind Corp Ltd 4-guanidinomethylcyclohexanecarboxylic acid ester and its preparation
JPS5721360A (en) 1980-07-14 1982-02-04 Teikoku Chem Ind Corp Ltd Allyl 4-guanidinomethylcyclohexanecarboxylate and its preparation
JPS5735556A (en) 1980-08-08 1982-02-26 Nippon Chemiphar Co Ltd Preparation of guanidinomethylcyclohexanecarboxylic acid ester
JPS5748958A (en) 1980-09-08 1982-03-20 Nippon Chemiphar Co Ltd Cyclohexanecarboxylic acid esters and their acid addition salts
JPS5748959A (en) 1980-09-08 1982-03-20 Nippon Chemiphar Co Ltd Preparation of cyclohexanecarboxylic acid derivative or its salt
JPS5748960A (en) 1980-09-08 1982-03-20 Nippon Chemiphar Co Ltd Novel cyclohexanecarboxylic acid derivative and its preparation
JPS5775922A (en) 1980-10-29 1982-05-12 Nippon Chemiphar Co Ltd Novel remedy for peptic ulcer
JPS5775921A (en) 1980-10-29 1982-05-12 Nippon Chemiphar Co Ltd Noval remedy for peptic ulcer
JPS5775920A (en) 1980-10-29 1982-05-12 Nippon Chemiphar Co Ltd Noval remedy for peptic ulcer
JPS57122059A (en) 1981-01-22 1982-07-29 Nippon Chemiphar Co Ltd Novel cyclohexanecarboxylic acid derivative and its preparation
JPS57122062A (en) 1981-01-22 1982-07-29 Nippon Chemiphar Co Ltd Novel trans-4-guanidinocyclohexanecarboxylic acid derivative and its preparation
JPS57126463A (en) 1981-01-29 1982-08-06 Nippon Chemiphar Co Ltd Novel carboxylic ester and its preparation
JPS57122060A (en) 1981-01-22 1982-07-29 Nippon Chemiphar Co Ltd Carboxylic acid ester and its preparation
JPS57122061A (en) 1981-01-22 1982-07-29 Nippon Chemiphar Co Ltd Novel cyclohexanecarboxylic acid derivative and its preparation
JPS57126462A (en) 1981-01-29 1982-08-06 Nippon Chemiphar Co Ltd Novel carboxylic ester and its preparation
JPS57126461A (en) 1981-01-29 1982-08-06 Nippon Chemiphar Co Ltd Novel guanidino compound and its preparation
JPS5838250A (ja) * 1981-09-01 1983-03-05 Teikoku Chem Ind Corp Ltd 複合体
JPS6254A (ja) 1985-03-08 1987-01-06 Kanebo Ltd 新規グアニジノメチルシクロヘキサンカルボン酸誘導体および該化合物を有効成分とする抗潰瘍薬
JPS6330462A (ja) 1986-07-24 1988-02-09 Taiyo Yakuhin Kogyo Kk 新規グアニジノメチルベンツアミド誘導体およびそれを有効成分とする抗潰瘍剤
JPS63218652A (ja) 1987-03-09 1988-09-12 Taiyo Yakuhin Kogyo Kk 新規グアニジノメチル安息香酸誘導体およびこれを含有する消化性潰瘍治療剤
JPH04217950A (ja) 1990-03-28 1992-08-07 Asahi Chem Ind Co Ltd ヒドロキサム酸誘導体および酵素阻害剤ならびに抗潰瘍剤
JP3073006B2 (ja) 1990-11-28 2000-08-07 株式会社日立製作所 聴覚機能補助装置
AU4993893A (en) * 1992-07-31 1994-03-03 Neose Pharmaceuticals, Inc. Compositions for treating and inhibiting gastric and duodenal ulcers
JP3150781B2 (ja) 1992-09-01 2001-03-26 株式会社資生堂 皮膚外用剤
JP3150780B2 (ja) 1992-09-01 2001-03-26 株式会社資生堂 皮膚外用剤
DE69316681T2 (de) 1992-08-27 1998-05-14 Shiseido Co Ltd Äusserliche, auf der Haut anzuwendende Depigmentierungsmittel enthaltende Zusammensetzung
JP3150782B2 (ja) 1992-09-01 2001-03-26 株式会社資生堂 皮膚外用剤
GB9221707D0 (en) * 1992-10-15 1992-12-02 Smithkline Beecham Plc Pharmaceutical composition
DE4339134A1 (de) * 1993-11-16 1995-05-18 Bayer Ag 1-(2-Fluorcyclopropyl)-chinolon- und -naphthyridoncarbonsäure-Derivate
JP3796612B2 (ja) * 1994-02-18 2006-07-12 ナガセケムテックス株式会社 抗菌剤
AUPM456894A0 (en) * 1994-03-18 1994-04-14 Glyzinc Pharmaceuticals Limited Treatment for gastric disorders
WO1996006825A1 (en) * 1994-08-30 1996-03-07 Teikoku Chemical Industries Co., Ltd. Guanidinomethyl cyclohexane carboxylic ester derivative
JP3046288B1 (ja) 1998-12-28 2000-05-29 京セラ株式会社 半導体・液晶製造装置用部材

Also Published As

Publication number Publication date
PT870500E (pt) 2008-05-07
US6444703B1 (en) 2002-09-03
TWI225786B (en) 2005-01-01
ATE386511T1 (de) 2008-03-15
TW457086B (en) 2001-10-01
US20020123508A1 (en) 2002-09-05
ES2301171T3 (es) 2008-06-16
AU763893B2 (en) 2003-07-31
DE69637442D1 (de) 2008-04-03
AU763893C (en) 2004-06-03
EP0870500A4 (en) 2001-09-12
DE69637442T2 (de) 2008-05-21
KR19990072207A (ko) 1999-09-27
AU1970901A (en) 2001-04-26
EP0870500A1 (en) 1998-10-14
KR100332280B1 (ko) 2002-06-20
WO1997023207A1 (en) 1997-07-03
JP3468244B2 (ja) 2003-11-17
AU1171697A (en) 1997-07-17
EP0870500B1 (en) 2008-02-20

Similar Documents

Publication Publication Date Title
NO974572D0 (no) Cyklodextrin-forbindelser, fremgangsmåter for fremstilling og anvendelse derav
DE69610751D1 (de) Elektronenemittierende Vorrichtung, Elektronenquelle und damit versehenes Bilderzeugungsgerät sowie Verfahren zu deren Herstellung
WO1989012624A3 (en) Coupling agents and sterically hindered disulfide linked conjugates prepared therefrom
AU687903B2 (en) Pharmaceutical composition containg a diclofanac salt and 2-hydroxypropyl-beta-cyclodextrin
DE69526428D1 (de) Verfahren zur erhöhung der bioverfügbarkeit oraler arzneimittel
FI945839L (fi) Bentsotiofeeniyhdisteiden ja vesiliukoisten syklodekstriinien inkluusiokompleksien vesipitoinen liuos ja niiden farmaseuttiset formulaatiot sekä menetelmä
PT870500E (pt) Agente anti-helicobacter pylori
ITBO920452A0 (it) "metodo per la realizzazione di protesi da implantologia e dispositivoper l'attuazione di tale metodo".
ATE433325T1 (de) Multimerer, rekombinanter urease impfstoff
ES2192245T3 (es) Emplastos que contienen principios activos.
FI103860B1 (fi) Glutaarialdehydiä ja 1,2-bentsisotiatsolin-3-onia sisältävä, vesipitoinen biosidinen koostumus ja menetelmä vesipohjaisen koostumuksen suojaamiseksi biologiselta kontaminaatiolta
FI955793A7 (fi) Menetelmä biohajoavan, hydrofobisen ja läpinäkyvän kalvon valmistamise ksi ja näin saatu kalvo
DE3773077D1 (de) Immunotoxine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DK0378303T3 (da) Undertrykkelse af mercaptanluft fra organothiophosphatbiocider
AU6580494A (en) Use of clioquinol for treating helicobacter, including (h. pylori), infections and related diseases
FI973105L (fi) Menetelmä (4,10-diasetoksi-2alfa-bentsoyylioksi-5beta,20-epoksi,1,7beta-dihydroksi-9-oksotaks-11-en-13alfa-yyli)-(2R,3S)-3-bentsoyyliamino-3-fenyyli-2-hydroksipropionaattitrihydraatin valmistamiseksi
ES2045154T3 (es) Procedimiento mejorado de precipitacion de vancomicina.
AU6701998A (en) Method for treatment of (h. pylori)
FI951655L (fi) H.pylori -infektioiden hoito
ITTO930410A0 (it) Procedimento e impianto per la trasformazione di rifiuti.
AU6134896A (en) Resolution of 1-azabicyclo{2.2.2}octan-3-amine, 2-(diphenylmethyl)-n -{{2-methoxy-5-(1-methylethyl)phenyl}methyl}
PT1121100E (pt) Processo de preparacao de uma solucao para pulverizacao nasal que contem uma ou mais hormonas sexuais e uma ciclodextrina
TR199901165A3 (tr) Piretroid bilesimi ve salgin hastaliklari için bunu içeren bilesikler.
ATE232361T1 (de) Pestizide formulierungen und verfahren zur deren herstellung
CA2486571A1 (en) Pharmaceutical composition